Wed, October 9, 2019
Tue, October 8, 2019
Mon, October 7, 2019
Fri, October 4, 2019
Thu, October 3, 2019
Wed, October 2, 2019
Tue, October 1, 2019
Mon, September 30, 2019
Fri, September 27, 2019
Thu, September 26, 2019
Wed, September 25, 2019
Tue, September 24, 2019
Mon, September 23, 2019
Fri, September 20, 2019
Thu, September 19, 2019
Wed, September 18, 2019
Tue, September 17, 2019
Mon, September 16, 2019
Fri, September 13, 2019

Joel Beatty Maintained (SRPT) at Strong Buy with Decreased Target to $180 on, Sep 27th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-180-on-sep-27th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joel Beatty of Citigroup, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Decreased Target from $185 to $180 on, Sep 27th, 2019.

Joel has made no other calls on SRPT in the last 4 months.



There are 5 other peers that have a rating on SRPT. Out of the 5 peers that are also analyzing SRPT, 0 agree with Joel's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Joel


  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $201 on, Tuesday, August 20th, 2019
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $181 on, Tuesday, August 20th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, August 20th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $220 on, Tuesday, July 9th, 2019
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $220 on, Monday, July 1st, 2019

Publication Contributing Sources